Glenmark Pharmaceuticals
GLENMARK.NS
$12.32
Share price
-1.48%
Change (1 day)
97.44%
Change (1 year)
Categories
Operating Margin for Glenmark Pharmaceuticals (GLENMARK.NS)
Operating Margin as of April 2024 (TTM): 9.57%
According to Glenmark Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is 9.57%. At the end of 2023 the company had an Operating Margin of 6.82%.
Operating Margin history for Glenmark Pharmaceuticals from 2012 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | 6.82% | -42.35% |
| 2022 | 11.84% | -7.46% |
| 2021 | 12.79% | 21.36% |
| 2020 | 10.54% | -18.67% |
| 2019 | 12.96% | 8.67% |
| 2018 | 11.93% | -16.1% |
| 2017 | 14.22% | 6.17% |
| 2016 | 13.39% | 46.95% |
| 2015 | 9.11% | -22.54% |
| 2014 | 11.76% | -19.63% |
| 2013 | 14.64% | 20.58% |
| 2012 | 12.14% | -25.66% |
| 2011 | 16.33% | 6.36% |
| 2010 | 15.35% | 20.82% |
| 2009 | 12.71% | -64.12% |
| 2008 | 35.41% | 22.66% |
| 2007 | 28.87% | 95.16% |
| 2006 | 14.79% | -28.87% |
| 2005 | 20.80% | 53.96% |
| 2004 | 13.51% |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.